Maxcyte (MXCT) Current Assets (2020 - 2026)

Maxcyte (MXCT) has 7 years of Current Assets data on file, last reported at $122.9 million in Q1 2026.

• Current Assets for Q1 2026 came in at $122.9 million, down 21.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $122.9 million (down 21.07% YoY), and the FY2025 annual result was $118.4 million, down 31.05% from the prior year.
• Current Assets advanced to $122.9 million in Q1 2026 per MXCT's latest filing, from $118.4 million in the prior quarter.
• Over five years, Current Assets peaked at $265.8 million in Q1 2022 and troughed at $118.4 million in Q4 2025.
• A 5-year average of $192.9 million and a median of $178.7 million in 2024 frame the typical range for Current Assets.
• The sharpest annual moves came in 2022 and 2025: Current Assets jumped 204.67% in 2022, then sank 31.05% in 2025.
• A 5-year view of Current Assets shows it stood at $252.3 million in 2022, then fell by 24.61% to $190.2 million in 2023, then declined by 9.73% to $171.7 million in 2024, then slumped by 31.05% to $118.4 million in 2025, then rose by 3.86% to $122.9 million in 2026.
• Business Quant data shows MXCT's Current Assets at $122.9 million in Q1 2026, $118.4 million in Q4 2025, and $124.6 million in Q3 2025.